Inhibition of myosin light chain kinase can be targeted for the development of new therapies against herpes simplex virus type-1 infection
udgivet i: Antiviral Therapy
dato for udgivelse: 2013-06-28
Cites articles
There is nothing here
Artikel - wd:Q39132809